1-3 of 3
Bas W. G. van Rhijn
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 1494: Silencing Notch-1 and Notch-3 promotes epithelial-to-mesenchymal transition (EMT) and self-renewal potential in human bladder cancer.

Wolfgang Jaeger, Tetsutaro Hayashi, Shannon Awrey, Kilian Gust, Thomas Cordonnier, Na Li, Ralph Buttyan, Estelle Li, Ladan Fazli, Theodorus Van Der Kwast, Bas W. G. Van Rhijn, Peter C. Black
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 1494.
https://doi.org/10.1158/1538-7445.AM2013-1494
Published: 15 April 2013
View article titled, Abstract 1494: Silencing Notch-1 and Notch-3 promotes epithelial-to-mesenchymal transition (EMT) and self-renewal potential in human bladder cancer.
Journal Articles

FGFR3 and P53 Characterize Alternative Genetic Pathways in the Pathogenesis of Urothelial Cell Carcinoma

Bas W. G. van Rhijn, Theo H. van der Kwast, André N. Vis, Wim J. Kirkels, Egbert R. Boevé, Adriaan C. Jöbsis, Ellen C. Zwarthoff
Journal: Cancer Research
Cancer Res (2004) 64 (6): 1911–1914.
https://doi.org/10.1158/0008-5472.CAN-03-2421
Published: 16 March 2004
View article titled, <em>FGFR3</em> and <em>P53</em> Characterize Alternative Genetic Pathways in the Pathogenesis of Urothelial Cell Carcinoma
Open the PDF for <em>FGFR3</em> and <em>P53</em> Characterize Alternative Genetic Pathways in the Pathogenesis of Urothelial Cell Carcinoma in another window
Journal Articles

The Fibroblast Growth Factor Receptor 3 (FGFR3) Mutation Is a Strong Indicator of Superficial Bladder Cancer with Low Recurrence Rate

Bas W. G. van Rhijn, Irene Lurkin, François Radvanyi, Wim J. Kirkels, Theodorus H. van der Kwast, Ellen C. Zwarthoff
Journal: Cancer Research
Cancer Res (2001) 61 (4): 1265–1268.
Published: 02 February 2001
View article titled, The Fibroblast Growth Factor Receptor 3 (<em>FGFR3</em>) Mutation Is a Strong Indicator of Superficial Bladder Cancer with Low Recurrence Rate
Open the PDF for The Fibroblast Growth Factor Receptor 3 (<em>FGFR3</em>) Mutation Is a Strong Indicator of Superficial Bladder Cancer with Low Recurrence Rate in another window